Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 450537

Multidrug resistance-associated P-glycoprotein phenotype impact on treatment response in B-CLL


Svoboda-Beusan, Ivna; Bendelja, Krešo; Kušec, Rajko; Pejša, Vlatko; Jakšić, Branimir; Vitale, Branko
Multidrug resistance-associated P-glycoprotein phenotype impact on treatment response in B-CLL // Haematologica 84 (EHA-4 Abstract Book)
Barcelona, Španjolska, 1999. str. 231-231 (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 450537 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Multidrug resistance-associated P-glycoprotein phenotype impact on treatment response in B-CLL

Autori
Svoboda-Beusan, Ivna ; Bendelja, Krešo ; Kušec, Rajko ; Pejša, Vlatko ; Jakšić, Branimir ; Vitale, Branko

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Haematologica 84 (EHA-4 Abstract Book) / - , 1999, 231-231

Skup
4th Congress of the European Haematology Association

Mjesto i datum
Barcelona, Španjolska, 09-11.06.1999

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
MDR; B-CLL; Pgp phenotype

Sažetak
Objective: The relevance of P-glycoprotein (Pgp), a marker of multidrug resistance (MDR) in B-CLL is controversial. The aim of our study was to investigate whether the MDR status at diagnosis correlates with the clinical data (modified Rai, total tumour mass (TM), total lymphocyte count (TLC) and therapy outcome. Design and Methods: Study population consisted of 42 patients (25 males, 17 females with a mean age 62±12 yrs). Expression of Pgp was analyzed on flow cytometer using two mAbs against intracellular (C-219) and extracellular (MRK-16) Pgp epitope. As, due to low Pgp expression, percent of Pgp+ cells is not an adequate value, therefore Pgp level was calculated as a ratio of mean fluorescence (Pgp specific/isotypic control, RMF) where RMF>1, 5 is considered as positive. Results: in 31 non-treated B-CLL patients elevated RMF (median C-219=3, 11 and MRK-16=2, 88) was found, with no correlation to TLC, TTM or modified Rai. We monitored patients who underwent chemotherapy with MDR-independent drugs (chlorambucil or purine analogs). Patients responding to therapy (complete or partial remission) had significant decrease of both C-219 and MRK-16 Pgp-RMFs (medians 6, 78 to 2, 43 and 3, 0 to 1, 35, respectively). The non-responders had unchanged or increased Pgp-RMF. Conclusions: Our data indicate the importance of MDR monitoring in an attempt to treat resistant B-CLL patients with MDR-related drugs.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
0021001

Ustanove:
Imunološki zavod d.d.

Poveznice na cjeloviti tekst rada:

Pristup cjelovitom tekstu rada

Citiraj ovu publikaciju:

Svoboda-Beusan, Ivna; Bendelja, Krešo; Kušec, Rajko; Pejša, Vlatko; Jakšić, Branimir; Vitale, Branko
Multidrug resistance-associated P-glycoprotein phenotype impact on treatment response in B-CLL // Haematologica 84 (EHA-4 Abstract Book)
Barcelona, Španjolska, 1999. str. 231-231 (poster, međunarodna recenzija, sažetak, znanstveni)
Svoboda-Beusan, I., Bendelja, K., Kušec, R., Pejša, V., Jakšić, B. & Vitale, B. (1999) Multidrug resistance-associated P-glycoprotein phenotype impact on treatment response in B-CLL. U: Haematologica 84 (EHA-4 Abstract Book).
@article{article, year = {1999}, pages = {231-231}, keywords = {MDR, B-CLL, Pgp phenotype}, title = {Multidrug resistance-associated P-glycoprotein phenotype impact on treatment response in B-CLL}, keyword = {MDR, B-CLL, Pgp phenotype}, publisherplace = {Barcelona, \v{S}panjolska} }
@article{article, year = {1999}, pages = {231-231}, keywords = {MDR, B-CLL, Pgp phenotype}, title = {Multidrug resistance-associated P-glycoprotein phenotype impact on treatment response in B-CLL}, keyword = {MDR, B-CLL, Pgp phenotype}, publisherplace = {Barcelona, \v{S}panjolska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font